UMediC Group Berhad Statistics

Total Valuation

UMediC Group Berhad has a market cap or net worth of MYR 224.35 million. The enterprise value is 211.45 million.

Market Cap	224.35M
Enterprise Value	211.45M

Important Dates

The next estimated earnings date is Thursday, March 6, 2025.

Earnings Date	Mar 6, 2025
Ex-Dividend Date	n/a

Share Statistics

UMediC Group Berhad has 373.91 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	373.91M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	23.15%
Owned by Institutions (%)	5.84%
Float	95.43M

Valuation Ratios

The trailing PE ratio is 25.16 and the forward PE ratio is 20.69. UMediC Group Berhad's PEG ratio is 0.74.

PE Ratio	25.16
Forward PE	20.69
PS Ratio	4.22
PB Ratio	3.04
P/TBV Ratio	3.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	0.74

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.76, with an EV/FCF ratio of -435.15.

EV / Earnings	23.63
EV / Sales	3.98
EV / EBITDA	15.76
EV / EBIT	19.46
EV / FCF	-435.15

Financial Position

The company has a current ratio of 10.32, with a Debt / Equity ratio of 0.01.

Current Ratio	10.32
Quick Ratio	7.22
Debt / Equity	0.01
Debt / EBITDA	0.05
Debt / FCF	-1.41
Interest Coverage	99.87

Financial Efficiency

Return on equity (ROE) is 12.88% and return on invested capital (ROIC) is 9.41%.

Return on Equity (ROE)	12.88%
Return on Assets (ROA)	8.49%
Return on Capital (ROIC)	9.41%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.66
Inventory Turnover	2.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.46% in the last 52 weeks. The beta is 0.12, so UMediC Group Berhad's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	-8.46%
50-Day Moving Average	0.61
200-Day Moving Average	0.64
Relative Strength Index (RSI)	44.76
Average Volume (20 Days)	80,530

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, UMediC Group Berhad had revenue of MYR 53.10 million and earned 8.95 million in profits. Earnings per share was 0.02.

Revenue	53.10M
Gross Profit	23.13M
Operating Income	10.87M
Pretax Income	12.45M
Net Income	8.95M
EBITDA	13.29M
EBIT	10.87M
Earnings Per Share (EPS)	0.02

Full Income Statement

Balance Sheet

The company has 14.37 million in cash and 685,000 in debt, giving a net cash position of 13.68 million or 0.04 per share.

Cash & Cash Equivalents	14.37M
Total Debt	685,000
Net Cash	13.68M
Net Cash Per Share	0.04
Equity (Book Value)	74.61M
Book Value Per Share	0.20
Working Capital	44.89M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.58 million and capital expenditures -6.06 million, giving a free cash flow of -485,919.

Operating Cash Flow	5.58M
Capital Expenditures	-6.06M
Free Cash Flow	-485,919
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 43.55%, with operating and profit margins of 20.47% and 16.85%.

Gross Margin	43.55%
Operating Margin	20.47%
Pretax Margin	23.44%
Profit Margin	16.85%
EBITDA Margin	25.03%
EBIT Margin	20.47%
FCF Margin	n/a

Dividends & Yields

UMediC Group Berhad does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	3.97%
FCF Yield	-0.22%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

UMediC Group Berhad has an Altman Z-Score of 19.52.

Altman Z-Score	19.52
Piotroski F-Score	n/a